These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
80 related articles for article (PubMed ID: 27423514)
1. miR-34a and its novel target, NLRC5, are associated with HPV16 persistence. Li J; Yu L; Shen Z; Li Y; Chen B; Wei W; Chen X; Wang Q; Tong F; Lou H; Chu M; Wei L Infect Genet Evol; 2016 Oct; 44():293-299. PubMed ID: 27423514 [TBL] [Abstract][Full Text] [Related]
2. miR-9, miR-21, miR-27b, and miR-34a Expression in HPV16/58/52-Infected Cervical Cancer. Liu M; Wang W; Chen H; Lu Y; Yuan D; Deng Y; Ran D Biomed Res Int; 2020; 2020():2474235. PubMed ID: 33015156 [TBL] [Abstract][Full Text] [Related]
4. MiR-34a Inhibits Viability and Invasion of Human Papillomavirus-Positive Cervical Cancer Cells by Targeting E2F3 and Regulating Survivin. Geng D; Song X; Ning F; Song Q; Yin H Int J Gynecol Cancer; 2015 May; 25(4):707-13. PubMed ID: 25675046 [TBL] [Abstract][Full Text] [Related]
5. MicroRNA-34a targets regulator of calcineurin 1 to modulate endothelial inflammation after fetal cardiac bypass in goat placenta. Yuan HY; Zhou CB; Chen JM; Liu XB; Wen SS; Xu G; Zhuang J Placenta; 2017 Mar; 51():49-56. PubMed ID: 28292468 [TBL] [Abstract][Full Text] [Related]
6. Tissue-Specific Gene Expression during Productive Human Papillomavirus 16 Infection of Cervical, Foreskin, and Tonsil Epithelium. Chatterjee S; Do Kang S; Alam S; Salzberg AC; Milici J; van der Burg SH; Freeman W; Meyers C J Virol; 2019 Sep; 93(17):. PubMed ID: 31189705 [TBL] [Abstract][Full Text] [Related]
7. CUL2 overexpression driven by CUL2/E2F1/miR-424 regulatory loop promotes HPV16 E7 induced cervical carcinogenesis. Xu J; Fang Y; Wang X; Wang F; Tian Q; Li Y; Xie X; Cheng X; Lu W Oncotarget; 2016 May; 7(21):31520-33. PubMed ID: 27153550 [TBL] [Abstract][Full Text] [Related]
8. Circulating miR-15b, miR-34a and miR-218 as promising novel early low-invasive biomarkers of cervical carcinogenesis. Ocadiz-Delgado R; Lizcano-Meneses S; Trejo-Vazquez JA; Conde-Perezprina JC; Garrido-Palmas F; Alvarez-Rios E; García-Villa E; Ruiz G; Illades-Aguiar B; Leyva-Vázquez MA; García-Carrancá A; Gariglio P APMIS; 2021 Feb; 129(2):70-79. PubMed ID: 33112434 [TBL] [Abstract][Full Text] [Related]
9. Dysregulated expression of microRNA-150 in human papillomavirus-induced lesions of K14-HPV16 transgenic mice. Santos JMO; Fernandes M; Araújo R; Sousa H; Ribeiro J; Bastos MMSM; Oliveira PA; Carmo D; Casaca F; Silva S; Teixeira AL; Gil da Costa RM; Medeiros R Life Sci; 2017 Apr; 175():31-36. PubMed ID: 28302562 [TBL] [Abstract][Full Text] [Related]
10. miRNA Expression Profiles of HPV-Infected Patients with Cervical Cancer in the Uyghur Population in China. Gao D; Zhang Y; Zhu M; Liu S; Wang X PLoS One; 2016; 11(10):e0164701. PubMed ID: 27764149 [TBL] [Abstract][Full Text] [Related]
11. Expression of miR-34a and miR-15b during the progression of cervical cancer in a murine model expressing the HPV16 E7 oncoprotein. Ocadiz-Delgado R; Cruz-Colin JL; Alvarez-Rios E; Torres-Carrillo A; Hernandez-Mendoza K; Conde-Pérezprina JC; Dominguez-Gomez GI; Garcia-Villa E; Lambert PF; Gariglio P J Physiol Biochem; 2021 Nov; 77(4):547-555. PubMed ID: 33937961 [TBL] [Abstract][Full Text] [Related]
12. HPV16 early gene E5 specifically reduces miRNA-196a in cervical cancer cells. Liu C; Lin J; Li L; Zhang Y; Chen W; Cao Z; Zuo H; Chen C; Kee K Sci Rep; 2015 Jan; 5():7653. PubMed ID: 25563170 [TBL] [Abstract][Full Text] [Related]
13. Expression profile of microRNA-146a along HPV-induced multistep carcinogenesis: a study in HPV16 transgenic mice. Araújo R; Santos JMO; Fernandes M; Dias F; Sousa H; Ribeiro J; Bastos MMSM; Oliveira PA; Carmo D; Casaca F; Silva S; Medeiros R; Gil da Costa RM J Cancer Res Clin Oncol; 2018 Feb; 144(2):241-248. PubMed ID: 29181576 [TBL] [Abstract][Full Text] [Related]
14. Verification of microRNA expression in human endometrial adenocarcinoma. Jurcevic S; Klinga-Levan K; Olsson B; Ejeskär K BMC Cancer; 2016 Apr; 16():261. PubMed ID: 27039384 [TBL] [Abstract][Full Text] [Related]
15. Unique microRNA expression profiles in cervical cancer. Gocze K; Gombos K; Juhasz K; Kovacs K; Kajtar B; Benczik M; Gocze P; Patczai B; Arany I; Ember I Anticancer Res; 2013 Jun; 33(6):2561-7. PubMed ID: 23749909 [TBL] [Abstract][Full Text] [Related]
16. Re-expression of HPV16 E2 in SiHa (human cervical cancer) cells potentiates NF-κB activation induced by TNF-α concurrently increasing senescence and survival. Prabhavathy D; Subramanian CK; Karunagaran D Biosci Rep; 2015 Feb; 35(1):. PubMed ID: 25572145 [TBL] [Abstract][Full Text] [Related]
17. MicroRNA-27b up-regulated by human papillomavirus 16 E7 promotes proliferation and suppresses apoptosis by targeting polo-like kinase2 in cervical cancer. Liu F; Zhang S; Zhao Z; Mao X; Huang J; Wu Z; Zheng L; Wang Q Oncotarget; 2016 Apr; 7(15):19666-79. PubMed ID: 26910911 [TBL] [Abstract][Full Text] [Related]
18. MiR-34a is involved in Tat-induced HIV-1 long terminal repeat (LTR) transactivation through the SIRT1/NFκB pathway. Zhang HS; Chen XY; Wu TC; Sang WW; Ruan Z FEBS Lett; 2012 Nov; 586(23):4203-7. PubMed ID: 23103739 [TBL] [Abstract][Full Text] [Related]
19. The expression of miR-21 and miR-143 is deregulated by the HPV16 E7 oncoprotein and 17β-estradiol. Gómez-Gómez Y; Organista-Nava J; Ocadiz-Delgado R; García-Villa E; Leyva-Vazquez MA; Illades-Aguiar B; Lambert PF; García-Carrancá A; Gariglio P Int J Oncol; 2016 Aug; 49(2):549-58. PubMed ID: 27278606 [TBL] [Abstract][Full Text] [Related]
20. miR-3156-3p is downregulated in HPV-positive cervical cancer and performs as a tumor-suppressive miRNA. Xia YF; Pei GH; Wang N; Che YC; Yu FS; Yin FF; Liu HX; Luo B; Wang YK Virol J; 2017 Feb; 14(1):20. PubMed ID: 28160779 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]